The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Drug And Gene Delivery Devices Market From 2026 To 2030?
The drug and gene delivery devices market size has demonstrated significant expansion in recent years. This market is anticipated to increase from $0.67 billion in 2025 to $0.73 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.9%. The historical progression can be linked to factors such as a scarcity of advanced delivery tools, a reliance on established administration routes, the early phases of gene therapy advancement, an expanding pipeline of biologics, and a rise in funding for research partnerships.
The drug and gene delivery devices market size is anticipated to experience substantial growth in the forthcoming years. It is projected to expand to $1.01 billion in 2030, achieving a compound annual growth rate (CAGR) of 8.6%. This expected rise in the forecast period stems from technological progress in viral and non-viral vectors, the expanding use of personalized medicine and gene therapy applications, an increase in regulatory clearances for inventive delivery systems, the growing embrace of nanomedicine and LNPs, and the incorporation of digital monitoring and smart delivery platforms. Noteworthy trends during this forecast timeframe include the development of targeted drug and gene therapies, the rising uptake of nanoparticle-based delivery systems, the increasing deployment of viral vectors for gene therapy, the widening array of injectable and non-invasive delivery methods, and a sharpened focus on personalized medicine and controlled release technologies.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19404&type=smp
What Drivers Are Influencing The Drug And Gene Delivery Devices Market?
The expanding use of gene therapy is anticipated to boost the growth of the drug and gene delivery devices market in the future. This medical method entails introducing, removing, or modifying genetic material inside a patient’s cells to manage or avert illnesses. Demand for gene therapy is increasing because it can address the underlying causes of genetic and chronic diseases, providing revolutionary treatment choices when traditional methods are insufficient. For gene therapy, drug and gene delivery devices are crucial for the accurate targeting and regulated release of therapeutic genes, thus improving treatment effectiveness. For example, in January 2025, the American Society of Gene & Cell Therapy, a US-based non-profit organization, reported that the count of pre-registration gene therapy programs in Q4 2024 saw its most significant rise in over a year, increasing by 83% compared to Q3 2024. Consequently, the expanding use of gene therapy is fueling the expansion of the drug and gene delivery devices market.
Which Segments Are Included In The Analysis Of The Drug And Gene Delivery Devices Market?
The drug and gene delivery devices market covered in this report is segmented –
1) By Vector: Viral, Non-viral
2) By Method: In Situ, Ex Vivo
3) By Route Of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical
Subsegments:
1) By Viral: Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors
2) By Non-Viral: Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels.
Which Trends Are Impacting The Growth Of The Drug And Gene Delivery Devices Market?
Leading companies in the drug and gene delivery devices market are prioritizing the creation of advanced products, such as those incorporating artificial intelligence (AI) technology, to secure a competitive advantage. AI technology in drug delivery involves employing AI techniques and algorithms to enhance the efficiency, precision, and overall effectiveness of drug delivery systems. As an illustration, in December 2023, Envoya Inc., a US-based developer known for polymer-based nanoparticles used in targeted delivery, unveiled an inventive gene therapy drug delivery platform. This new platform integrates biopolymer-nanoparticles with artificial intelligence (AI) to tackle considerable limitations present in existing gene therapy technologies, including viral vectors and lipid nanoparticles. Its objective is to surmount the constraints of current gene therapy delivery methods, which have been hampered by issues such as safety concerns, constrained payload capacities, and insufficient tissue targeting.
Which Key Industry Participants Are Active In The Drug And Gene Delivery Devices Market?
Major companies operating in the drug and gene delivery devices market are Medtronic plc, Moderna Inc., Halozyme Therapeutics Inc., Uniqure NV, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics, Pfizer Inc., Novartis AG, Becton Dickinson and Company, Shanghai Sunway Biotech Co Ltd, Epeius Biotechnologies Corporation, SiBiono GeneTech Co Ltd, F Hoffmann-La Roche Ltd, Baxter International, B Braun Melsungen, Terumo Corporation, ICU Medical, Stevanato Group, Gerresheimer AG, Ypsomed, SHL Medical
Read the full drug and gene delivery devices market report here:
Which Regions Are Expected To Experience Rapid Expansion In The Drug And Gene Delivery Devices Market?
North America was the largest region in the drug and gene delivery devices market in 2025. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Drug And Gene Delivery Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19404&type=smp
Browse Through More Reports Similar to the Global Drug And Gene Delivery Devices Market 2026, By The Business Research Company
Gastrointestinal Drug Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report
Hematology Drug Market Report 2026
https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report
Metabolic Disorders Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model